Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF FIBROSIS
Document Type and Number:
WIPO Patent Application WO/2022/240036
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition that can be usefully used for the prevention or treatment of fibrosis. By using a first component and a second component together according to the present invention, the prevention or treatment effect on fibrosis can be further enhanced.

Inventors:
BAE DA JEONG (KR)
LEE CAROLINE HEE (KR)
CHO MIN JAE (KR)
PARK MIN YOUNG (KR)
KIM JI HYEON (KR)
PARK JOON SEOK (KR)
Application Number:
PCT/KR2022/006231
Publication Date:
November 17, 2022
Filing Date:
May 02, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
DAEWOONG PHARMACEUTICAL CO LTD (KR)
International Classes:
A61K31/454; A61K31/4418; A61K31/496; A61P11/00; A61P43/00
Domestic Patent References:
WO2010018134A12010-02-18
Foreign References:
US20190282565A12019-09-19
KR102084772B12020-03-04
KR102084772B12020-03-04
Other References:
LEE C.H., CHO M., KIM J.M., LEE J.H., KIM D.-W., PARK M.Y., KIM Y.K., HAN J., PARK J.S.: "A First-in-Class PRS Inhibitor, DWN12088, as a novel therapeutic agent for idiopathic pulmonary fibrosis", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, vol. 201, 1 January 2020 (2020-01-01), US , pages A2786, XP009541055, ISSN: 1073-449X
SONG DAE-GEUN, KIM DOYEUN, JUNG JAE WOO, NAM SEO HEE, KIM JI EON, KIM HYE-JIN, KIM JONG HYUN, PAN CHEOL-HO, KIM SUNGHOON, LEE JUNG: "Glutamyl-Prolyl-tRNA Synthetase Regulates Epithelial Expression of Mesenchymal Markers and Extracellular Matrix Proteins: Implications for Idiopathic Pulmonary Fibrosis", FRONTIERS IN PHARMACOLOGY, vol. 9, no. 1337, pages 1 - 11, XP093004347, DOI: 10.3389/fphar.2018.01337
NATURE, vol. 494, 2013, pages 121 - 125
NAT. REV. CANCER, vol. 11, 2011, pages 708 - 718
Attorney, Agent or Firm:
YOU ME PATENT AND LAW FIRM (KR)
Download PDF: